City of Hope Expands Cancer Treatment Access with New National Trial Network

City of Hope Expands Cancer Treatment Access with New National Trial Network

2025-09-10 transformation

Duarte, Wednesday, 10 September 2025.
City of Hope has launched a national clinical trial network on 8 September 2025, significantly increasing patient access to innovative cancer treatments across the United States.

Enhanced Accessibility Through a Broad Network

City of Hope’s new national clinical trial network, launched on 8 September 2025, is designed to significantly broaden access to cutting-edge cancer treatments across the United States. With 37 locations spread throughout major cities such as Los Angeles, Orange County, Phoenix, Chicago, and Atlanta, the initiative ensures that millions of Americans are within a 90-minute drive of a trial site. This strategic placement is set to reduce patient enrollment times, increase participation rates, and ensure that patients nationwide have access to the latest cancer treatment options [1][2].

Personalized Medicine and Supportive Care

The network emphasizes personalized medicine, tailoring care to the specific needs of each patient. By integrating supportive care programs, City of Hope aims to provide comprehensive treatment that goes beyond conventional methods. This approach is part of their commitment to offering patients promising new treatment options long before these become standard care, as emphasized by Edward S. Kim, MD, FACP, FASCO [1][2].

Collaborative Efforts and Technological Integration

City of Hope’s collaboration with Eli Lilly and Company highlights the network’s focus on creating a centralized model that not only saves time and resources but also enhances the quality of research. Furthermore, the deployment of HopeLLM, an AI platform developed by City of Hope, aims to streamline clinical workflows and improve patient care by synthesizing complex medical histories into actionable summaries. This integration of technology is set to standardize care delivery across the network, ensuring high-quality interactions between clinicians and patients [3][4].

Long-term Impact on Cancer Treatment

This national initiative is a significant step in transforming the landscape of cancer treatment in the United States. By focusing on accessibility, personalized care, and technological innovation, City of Hope is setting a precedent for future healthcare models. The network’s ability to open trials simultaneously across multiple locations ensures rapid advancement in cancer research and treatment, providing hope for improved patient outcomes in the long term [1][2][3].

Bronnen


personalized medicine cancer clinical trials